The Immigration Laws and Policy in the United States of America

Figure S3. Line plot of the absolute number of cells per lymphocyte subset in 68 non-converting and 17 converting patients with arthralgia. The non-converting patients are depicted from the time point of inclusion. The converting patients are depicted from the time point of conversion and the time before conversion. (TIF 1784 kb

Additional file 3: of Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials

Funnel plots of a DAS28 < 2.6, b ACR20, c ACR50 responses, d ACR70 responses, e AEs and f SAEs. Funnel plots of efficacy and safety outcomes for the following treatment-control combinations: (1) TCZMONO vs. TCZCOMBI; (2) TCZMONO vs. csDMARD; and (3) TCZCOMBI vs. csDMARD. (DOCX 63 kb

Additional file 1: of Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy

Baseline characteristics of the patients included in the analyses. (DOCX 17 kb

Additional file 2: of Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy

Description of the differentially co-expressed genes in the salmon module (tocilizumab plus methotrexate arm), the purple module (tocilizumab arm), and the black module (methotrexate arm). (DOCX 22 kb

Additional file 6: of Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?

Clinical parameters at baseline associated with current miRNA levels. Serum values of the four selected miRNAs were tested for their relationship with clinical parameters, independent from response. (DOCX 16 kb

Additional file 2: of Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?

Baseline characteristics of patients in the discovery and validation cohort, split for received treatment. (DOCX 19 kb

Solanum maximowiczii Koidz.

原著和名: マルバノホロシ科名: ナス科 = Solanaceae採集地: 静岡県 巣雲山 (伊豆 巣雲山)採集日: 1966/9/15採集者: 萩庭丈壽整理番号: JH001157国立科学博物館整理番号: TNS-VS-95115

Additional file 2: of Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients

Figure S2. Dot plots of the absolute number of cells in the lymphocyte subsets in 37 healthy controls (HC), 40 patients with arthralgia who developed arthritis within 5 years (converters), 73 patients with arthralgia who did not develop arthritis (non-converters) and 89 patients with early RA (EAC). The black line represents median of the whole group. Differences between groups were tested with the Kruskal-Wallis test followed by Dunn’s multiple comparison test. N.S. not significant. (TIF 791 kb

Additional file 1: Table S1. of Physiological evidence for diversification of IFNι- and IFNβ-mediated response programs in different autoimmune diseases

List of 23 type I interferon (IFN) response genes that were measured. Table S2. List of genes that are significantly differentially expressed between patients with systemic lupus erythematosus (SLE) and patients with multiple sclerosis (MS) who were treated with IFNβ. (PDF 116 kb